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Abstract 
Aims: Identification of characteristics and trends over time in young injecting drug users at first 
attendance at needle exchange. Design: Retrospective cross-sectional survey of routinely collected 
data. Setting: Dublin needle exchange programme which consists of 11 sites in the greater Dublin 
area. Participants: First-time attenders (n = 1224) at the needle exchange from 1990 to 1997, 
between the ages of 15 and 19.  Measurement: Factors associated with a likelihood of needle 
sharing and condom use were tested using logistic regression. Findings: Increases in both the 
number and proportion of young injectors, particularly young female injectors, have occurred over the 
8 years. Forty-eight per cent of the young injectors were injecting for less than 1 year. Needle sharing 
prevalence in the year previous to first attendance was 39% and condom use was 61%. The 
proportion of females not using a condom during sexual relationships was significantly higher than 
males. Very few of the young attenders had received any treatment for drug dependence. 
Conclusions: After the first year of injecting drug use the likelihood of needle sharing increased and 
we recommend that interventions occur early on and are targeted to the needs of young injecting 
drug users, in particular young females. It is essential that services are accessible to the young 
injecting drug user and that barriers to contact with services are minimized or eliminated. Some high-
risk behaviours are occurring in the context of the sexual relationship and this should be taken into 
account when designing prevention programmes, especially for young females. 
 
Introduction 
The total number of injecting drug users in Ireland is unknown, but is estimated to be at least 13 000–
14 000 in the greater Dublin area.1 In Ireland, 98% of heroin misusers in treatment are resident in the 
Eastern Health Board (EHB) region.2 The EHB is responsible for health services in Dublin City and 
county and counties Kildare and Wicklow, population 1 245 225 (1991 census). Dublin is the centre 
for opiate use in Ireland and there is little evidence of injecting drug use outside this region.2 
 
The 1997 Annual Report of the European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA) indicates that Ireland has the youngest mean age of treated drug use in Europe at 23.6 
years and two-thirds of treated drug users are under the age of 25 years.3 The treated drug user 
statistics do not include data from needle exchange, which is not designated a treatment service. 
 
In 1989 the first needle exchange was established by the EHB in an inner city location. The number 
of exchanges has grown steadily to meet demand for increased and localized services. Services have 
expanded from city centre locations to servicing needs in satellite clinics in suburban areas. A mobile 
clinic has also been established, bringing the total number of clinics to 11. Injecting drug users are at 
high risk for infection with the human immunodeficiency virus 
(HIV) 4 and hepatitis.5, 6 The estimated rate of HIV in the European Union adult population aged 15–
59 years is 198 cases per 100 000, 42% of cases being injecting drug use-related.4 Needle exchange 
programmes are designed to meet the needs of drug users who are unwilling or unable to cease 
injecting. The clients of needle exchange have been largely male, older and longer-term 
injectors.7, 8 The aim of needle exchange is to reduce the transmission of blood-borne infection.  
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9 The Dublin needle exchange programme encourages a reduction or cessation in the sharing of 
injecting equipment and unsafe sexual practices. The exchanges supply sterile injecting equipment 
and safe injecting instruction. Contact with outreach workers for education, counselling and referral to 
treatment services is also provided. The needle exchanges are made as accessible as possible with 
no or low thresholds for eligibility. This includes a walk-in service, no waiting list, minimal identification 
requirements and informal relationships with staff. The contact and building of relationships with 
trained staff provides a potentially important channel to other services.  
 
Needle exchanges are largely funded and staffed by the health board but are separate from treatment 
and rehabilitation addiction services. This facilitates a low threshold and easy access to the service. 
One large city-centre needle exchange is administered by a voluntary agency but reports data to the 
EHB database. The locations are varied and include health centres, clinics and community hospitals. 
The exchanges do not supply methadone maintenance treatment. 
 
There are few studies specifically concerned with young injectors. A Dutch cohort study found that a 
number of young users (under 25 years of age) had short injecting histories and had a lower 
seroprevalence of HIV than the whole cohort.10 Young injectors and particularly recent onset injectors 
were found to be at greater risk of HIV infection than the older and longer-term users due at least in 
part to behavioural factors. In another study, newly initiated injectors were at particular risk of sero-
conversion compared to the group as a whole because of an increased level of sharing of injecting 
equipment. 11 A recent study in Dublin found drug users aged under 25 significantly more likely to 
report borrowing and lending used injecting equipment compared to older drug users.12 The objective 
of the present study was to establish demographic characteristics, drug-taking characteristics and risk 
behaviours of first-time attenders at needle exchanges, aged between 15 and 19 years. In addition, 
trends over time were identified. 
 
Methods 
The study population consisted of 1224 injecting drug users aged 15–19 inclusive attending the 
Dublin needle exchange programme for the first time between 1990 and 1997 inclusive. The data are 
a subset (21%, 1224/5778) of a larger database of the Dublin needle exchange. Data from the whole 
sample are presented throughout the paper for comparison purposes. The first needle exchange site 
in Dublin was established mid-year in 1989 and data from this year were excluded. 
 
All data on first attendance for the years 1990– 97 inclusive were used in the analysis. The database 
was established at the initiation of the needle exchange programme. All needle exchange programme 
sites participate in the system. Specially trained outreach workers run the needle exchanges. 
Outreach workers collect the data in a face-to-face interview with the drug user at first presentation 
and at each subsequent visit. Data are collected on all attendees, who are asked only for their first 
and last initials and their date of birth. Names are not requested but initials and date of birth are 
collected in order to prevent duplication of data due to multiple presentation. During the first 
attendance, detailed data are recorded on a standard ‘4 x 6’ card. A unique number is assigned at a 
central location where data from all the clinics are coded by a designated clerical officer and entered 
into the Health Board’s mainframe computer. The database is checked for duplications. 
 
Data form content 
At first attendance the following data are recorded. 
• Socio-demographics: initials, sex, date of birth, date of visit, area of residence. 
• Drug injecting and other characteristics: number of years of injecting drug use, primary drug of 
use, reported hepatitis and/or jaundice since initiation of injecting, number of detoxifications 
received, currently attending methadone maintenance treatment, interest in receiving 
methadone treatment, year of last HIV test and condoms taken at visit. 
• Risk behaviours: needle sharing, number of sexual partners and condom use 
 
The risk behaviour questions asked were: ‘Have you shared needles in the previous year?’ ‘How 
many sexual partners have you had in the previous year?’ and ‘Have you used condoms during 
sexual encounters in the previous year?’ No further details on these variables were elicited. The data 
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form was designed to be filled out quickly and provide simple comparable quantitative data between 
the clinics and over time. The risk behaviour questions were designed to be answered in an 
‘always/sometimes/never’ format, but were also in practice answered in a ‘yes/no’ format.  
 
Therefore responses were recoded so that for the variable ‘needle sharing’ responses ‘always’, 
‘sometimes’ and ‘yes’ were coded as positive responses and ‘never’ was coded as a negative 
response. For the variable ‘condoms use’ responses ‘always’ and ‘yes’ were coded as positive 
responses and ‘sometimes’ and ‘never’ were coded as a negative response. 
 
Data analysis 
Data were downloaded from the mainframe health board computer and analysed using the SAS 
institute Jump In® programme and Epi-Info 6. Data were screened, and recoding and reconciling of 
codes took place at this time. Frequency distributions were completed for all nominal variables and 
means, medians and ranges were computed for continuous variables. 
 
To test association between variables, Pearson’s chi-square tests and Fisher’s exact test were used 
for univariate comparisons. For assessing trend, chi-square tests for trend were used. Continuous 
variables—age, number of years injecting and number of sexual partners—did not have normal 
distributions and were recoded to categorical variables after means, medians and ranges were 
obtained.  
 
Factors associated with a likelihood of needle sharing and condom use were tested using logistic 
regression. Logistic regression was undertaken and two models were run with one looking at needle 
sharing and the other at condom use. Not using a condom was used as the dependent variable as 
the lack of condom use indicates the presence of risk. Variables were prepared for logistic regression 
analysis by transformation to binomial categories or dummy variables were created. Variables for 
logistic regression were initially entered independently and odds ratios with 95% confidence intervals 
were computed. Variables were then grouped into socio-demographic, drug behaviour and risk 
behaviour categories and run separately through a multiple logistic regression. Variables that were 
statistically significant and variables thought to be relevant and important were retained. A final model 
was fitted using these variables and different combinations were tried resulting in a final model. 
Interactions were tested for in the final model. 
 
Results 
Demographics of young injectors 
The overall trend in the number of young injecting drug users attending the Dublin needle exchange 
programme increased between 1990 and 1997 (Table 1). Data from the whole sample are presented 
in the table for comparison purposes. There was a significant increase in the proportion of young 
injectors when analysing the whole sample, X2tr = 215.87, p =< 0.0001. 
 
There was also a significant increase in the proportion of females in the young age group, X2tr = 
19.40, p =< 0.0001. The total number of attenders aged 15–19 was 1224. Due to missing data or 
unusable data this denominator changes with different variables. The mean age of attenders in the 
15–19 age group was 18.59 (SD5 0.99), median age 18. The mean age of attenders in the whole 
sample of needle exchange attenders was 25.0 (SD5 5.8), median age 23, range 15–58. 
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Table 1. Number and gender of attenders age 15 to 19 and overall numbers of needle exchange 
attenders, 1990–1997 
Male Female 
Year of attendance N % N % 
No. of 15–19/ no. in 
whole sample Proportion % 
1990 38 86 6 14 44/345 13 
1991 15 94 1 6 16/228 7 
1992 58 88 8 12 66/587 11 
1993 119 74 41 26 160/904 18 
1994 164 80 42 20 206/948 22 
1995 216 79 59 21 275/1217 23 
1996 138 68 65 32 203/652 31 
1997 169 68 80 32 249/910 27 
Total 917  302  1219/5791 21 
 
 
Number of years injecting 
Forty-eight per cent (584/1212) of the young injectors had been injecting for less than 1 year and 98% 
(1188/1212) had been injecting for less than 5 years. This compared with 29% (1686/ 5728) of the 
whole sample, with an injecting duration of under 1 year and 69% (3974/5728) under 5 years. 
Specific durations of less than 1 year (days/weeks/months) were not recorded.  
 
The primary drug of use was heroin 853/1006 (85%). During the early 1990s there was a proliferation 
of morphine sulphate tablets in Dublin and this largely accounts for the other 15%. 
 
Treatment and exchange services 
Methadone treatment services were not provided at the exchanges but referral to treatment services 
was facilitated. Eight per cent (79/1010) of young injectors reported that they were currently receiving 
methadone treatment from treatment services, which are separate from needle exchange services. 
Interest in receiving methadone treatment was high at 76% (779/1022). Very few of the young 
attenders had received any treatment; 73% (871/1192) had never attended a detoxification 
programme. Twenty-three per cent (283/1224) of young injectors reported having had an HIV test. 
The interval between the HIV test and first attendance at needle exchange is 1 year or less for 89% 
(250/282) of cases. Information on results of HIV test is unknown. 
 
Number of sexual partners 
The number of sexual partners in the previous year for young injectors is shown in Table 2. The mean 
number of sexual partners in the previous year was 3.06, median was 2 and inter-quartile range (IQR) 
was 1–3. There was a range of 1–40 partners. This compared to the whole sample in which the mean 
number of sexual partners in the previous year was 2.55, median was 1.0 and IQR 1–3. There was a 
range of 1–100 partners. The means exclude people who had no sexual partners in the previous 
year. 
 
 
Table 2. Number of sexual partners of young injectors in the previous year 
 Male Female Total 
No. of sexual partners N % N % N % 
None 144 16 55 19 199 17 
One 321 36 172 58 493 41 
More than one 428 48 70 24 498 42 
Totals 893  297  1190  
X2 = 58.32, p = < 0.0001. 
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Table 3. Trends in needle sharing and condom use for attenders age 15–19 
 Needle sharing Condom use 
 15–19 All attenders 15–19 All attenders 
Year N % N % N % N % 
1990 15 47 106 43 7 54 48 53 
1991 4 33 83 40 4 57 53 43 
1992 31 50 281 51 31 59 260 53 
1993 62 40 371 44 93 55 391 52 
1994 64 37 287 37 95 57 379 52 
1995 79 34 379 36 146 65 543 57 
1996 65 34 181 31 111 62 291 55 
1997 104 45 332 40 139 66 474 63 
Total 424 39 2020 39 626 61 2439 55 
 
Gender 
The proportion of 15–19-year-old females not using a condom during sexual relationships was 
significantly higher than males 48% (130/271) vs. 36% (304/839), X2 = 11.85, p = 0.0007. This is 
similar to the whole sample in which significantly more females reported not using a condom during 
sexual relationships in the previous year than males, 51% (524/1027) vs. 44% (1804/4125), X2 = 
17.64, p =< 0.0001)  
 
Females had a higher prevalence of needle sharing than males, but this result was not statistically 
significant, 42% (113/267) vs. 38% (310/814), X2 = 1.5, p = 0.22. This compares with the whole 
sample in which significantly more females reported needle sharing in the previous year than males, 
44% (448/1012) vs. 38% (1568/4117), X2 = 13.02, p = 0.0003). 
 
Needle sharing 
Young injectors had a 39% (424/1087) needle sharing prevalence in the previous year, no different 
than the whole sample 39% (2020/5129), X2 = 0.05, p = 0.83. Needle sharing prevalence  fluctuated 
from year to year with no significant decreasing trend over time in the young group (X2tr = 0.17, p = 
0.68), and a significant decreasing trend in the older group (X2tr = 0.24.8, p = < 0.0001) (Table 3). 
Recent injectors, and those who use condoms, are less likely to share needles. Needle sharing is 
more likely in injectors with more than one sexual partner and those reporting hepatitis or jaundice 
(Table 4). 
 
Table 4. Characteristics associated with needle sharing in injecting drug users age 15–19 at first 
attendance 
 N (%) Crude OR 95% CI Adjusted OR 95%CI 
Sex      
Female 302 (25) 1    
Male 917 (75) 0.82 0.62–1.09   
Injecting duration      
≥ 1 year 628 (52) 1  1  
< 1 year 584 (48) 0.69 0.54–0.88 0.70 0.51–0.95 
Condom use in the 
previous years 
     
No 434 (39) 1  1  
Yes 676 (61) 0.50 0.38–0.65 0.48 0.35–0.65 
Sexual partners in 
previous year 
     
None 199 (17)     
One 493 (41) 1  1  
> One 498 (42) 1.34 1.03–1.75 1.47 1.08–1.99 
Self-report of 
hepatitis/jaundice 
     
No 801 (87) 1  1  
Yes 115 (13) 2.06 1.38–3.08 1.75 1.12–2.72 
776 observations for multivariate analysis. 
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Table 5. Characteristics associated with lack of condom use in injecting drug users age 15–19 at first 
attendance 
 N (%) COR 95% CI AOR 95%CI 
Sex      
Female 302 (25) 1    
Male 917 (75) 0.59 0.44–0.79   
Injecting duration      
≥ 1 year 628 (52) 1    
< 1 year 584 (48) 0.93 0.73–1.18   
Needle sharing in 
previous year 
     
No 658 (61) 1  1  
Yes 423 (39) 2.00 1.53–2.63 2.31 1.70–3.16 
Sexual partners in 
previous year 
     
None 199 (17)     
One 493 (41) 1  1  
> One 498 (42) 0.57 0.44–0.74 0.55 0.41–0.75 
Condoms taken at visit      
No 362 (43) 1  1  
Yes 471 (57) 0.43 0.33–0.56 0.33 0.25–0.45 
796 observations for multivariate analysis. 
 
Condom usage 
Excluding those that did not have a sexual partner in the previous year, 61% (676/1110) reported 
condom usage. Young injectors’ condom use was significantly higher than the overall population 
(61% (601/980) vs. 53% (1822/3418), X2 = 19.8, p =< 0.0001). Condom use increased significantly 
over the 8 years in the young injectors (X2tr = 5.21, p = 0.02) and in the overall group (X2tr = 22.4, p =< 
0.0001) (Table 3). Young injectors with more than one sexual partner in the previous year were more 
likely to use condoms during sex than injectors with one partner (68%, 334/493 vs. 55%, 267/487, X2 
= 17.25, p =< 0.0001). 
 
The logistic regression analysis is shown in Table 5. The study found that the characteristic most 
associated with lack of condom use in the previous year was needle sharing. Male injectors were 
more likely to use condoms. Injectors with more than one sexual partner and those that took condoms 
at the visit were also more likely to use condoms. 
 
Discussion 
We have found evidence that both the number and proportion of young injectors has increased 
significantly over the 8 years of the needle exchange programme. This study provides a quantitative 
data analysis of Dublin’s needle exchange database. Characteristics of injectors aged 15–19 are 
described and prevalence of risk behaviours and trends over time at first attendance were identified. 
A limitation of this study is that, as it is based on an analysis of a routine data source, some 
explanatory details on drug taking and risk behaviour are absent. Therefore, we are unable to provide 
data on lending and borrowing, or details of sexual partners. Because the study is essentially a series 
of cross-sectional studies and not a cohort study there is a potential danger of over interpretation. The 
data consist of self reported measures from drug users and there is no objective confirmation of the 
validity of answers.  However, findings in other studies support the use of retrospective self reports 
and have found self-reported drug use and risk behaviour of injecting drug users reliable.13, 14
 
In other countries, needle exchange attendance is generally associated with older injecting drug 
users and injectors with long injecting careers but in this study young injectors presented at the 
needle exchange in increasingly large numbers. These young injectors had recent onset of injecting, 
and half had been injecting less than 1 year. Risk behaviour was evident with many reporting needle 
sharing in the previous year. Needle exchange was the first contact with services for many as few 
had received treatment.  
 
Please use the following citation: Barry J and Mullen L (2001) An analysis of 15–19-year-old first attenders at the Dublin Needle Exchange, 
1990–97 (Author postprint) in Addiction 96(2), 251–258 [Accessed: (date) from http://ndc.silverarm.com/6521/]  
 
6
In this study, needle sharing prevalence was the same in the younger age group as the overall group 
of attenders at needle exchange. This could be due to the young age of the overall group. We have 
found that needle sharing was more likely in drug users who had been injecting one year or more. 
Needle sharing was associated with having more than one sexual partner and was less likely when 
condom use was reported. This requires more qualitative analysis to interpret the complex 
relationship between injecting and sexual risk behaviours. 
 
There was a trend of increased use of condoms over the study period. Eighty-four per cent of young 
injectors had been sexually active in the year previous to their first attendance at needle exchange. 
Condom use was more likely in the 15–19 age group compared to the overall group of attenders. In 
1993 there was a change in the law in Ireland, making condoms more readily available, although 
clearly they were available before this time. Injectors with multiple sexual partners appear to be 
protecting themselves by using condoms compared to those with one sexual partner. Females had a 
significantly lower prevalence of condom use compared to males. 
 
Almost two-thirds of females in this study reported having had only one sexual partner in the previous 
year. Other studies found women injectors are often in relationships with injecting men and are less 
likely to use condoms.15 The sexual relationship as the context for risk behaviour is important to 
consider in prevention programmes. Where risks are being taken as part of a sexual partnership 
targeting the couple for intervention must be considered.16  
 
The potential for intervention and prevention in this young cohort has important public health 
implications. Prevention measures may not have initially been envisioned to be needed by such a 
young population and may not be targeted enough. Young injectors’ early appearance at needle 
exchange may indicate an awareness of the risks of sharing needles and a concern to protect 
themselves. The number of recent onset injectors presents an opportunity for intervention and health 
service provision and. emphasizes the importance of early preventive interventions. Every effort must 
be made to ensure that services are accessible and effective so that young people are encouraged to 
embrace the wider services that are available to them and that they are protected from infection and 
the social disintegration that can occur with prolonged drug misuse. The progress of individuals from 
services such as needle exchange to treatment services should be strengthened without 
compromising the low threshold accessibility and acceptability of the needle exchanges. It is 
important that young people do not encounter barriers to service from policies, such as parental 
permission or mandatory treatment. 
 
The information gained from this analysis of the needle exchange programme can be used to identify 
groups within the drug injecting community that may need prevention and service programmes 
targeted to their needs. Young injectors have specific needs that can be met by a service willing to 
address them. Attention should be paid to young female injectors who may need services that take 
into account their patterns of behaviour and the presence of sexual partners in their lives. 
 
Qualitative research in this population will help fill in the gaps of understanding and knowledge with 
regard to this drug injecting group. Injecting drug users in Dublin come largely from marginalized 
areas of the city where poor socioeconomic conditions are the norm. Prevention initiatives will be 
greatly enhanced by a better understanding of the issues surrounding drug use, risk management 
and sexual relationships. Of equal importance are social initiatives to address the causes of the 
problem, including tackling social deprivation and marginalization. 
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